Respiratory infections unique to Asia

Kenneth W Tsang, Thomas M File Jr, Kenneth W Tsang, Thomas M File Jr

Abstract

Asia is a highly heterogeneous region with vastly different cultures, social constitutions and populations affected by a wide spectrum of respiratory diseases caused by tropical pathogens. Asian patients with community-acquired pneumonia differ from their Western counterparts in microbiological aetiology, in particular the prominence of Gram-negative organisms, Mycobacterium tuberculosis, Burkholderia pseudomallei and Staphylococcus aureus. In addition, the differences in socioeconomic and health-care infrastructures limit the usefulness of Western management guidelines for pneumonia in Asia. The importance of emerging infectious diseases such as severe acute respiratory syndrome and avian influenza infection remain as close concerns for practising respirologists in Asia. Specific infections such as melioidosis, dengue haemorrhagic fever, scrub typhus, leptospirosis, salmonellosis, penicilliosis marneffei, malaria, amoebiasis, paragonimiasis, strongyloidiasis, gnathostomiasis, trinchinellosis, schistosomiasis and echinococcosis occur commonly in Asia and manifest with a prominent respiratory component. Pulmonary eosinophilia, endemic in parts of Asia, could occur with a wide range of tropical infections. Tropical eosinophilia is believed to be a hyper-sensitivity reaction to degenerating microfilariae trapped in the lungs. This article attempts to address the key respiratory issues in these respiratory infections unique to Asia and highlight the important diagnostic and management issues faced by practising respirologists.

Figures

Figure 1
Figure 1
CXR of a 42‐year‐old woman who had contact with a SARS patient and then developed fever 3 days later (a) showing bilateral lower lobe mild ground glass consolidation, which rapidly progressed to bilateral ground glass consolidation after 24 h (b). SARS, severe acute respiratory syndrome.
Figure 2
Figure 2
High‐resolution CT thoracic scan of a 32‐year‐old man who contracted H5N1 infection, who developed bilateral ground glass pneumonitis and ARDS showing bilateral ground glass consolidation in the lower lobes. The patient also developed multi‐organ failure requiring intensive care therapy.
Figure 3
Figure 3
CXR of a 52‐year‐old man who had haemoptysis, fever and malaise showing right upper lobe lung abscess and mild surrounding consolidation. Serology confirmed the presence of a fourfold rise in IgG against Burkholderia pseudomallei, which was also detected on culture of BAL fluid obtained from the right upper lobe anterior segment.
Figure 4
Figure 4
High‐resolution CT thoracic scan of a 62‐year‐old lady, a frequent visitor of Cambodia, who developed high fever, headache, respiratory failure, generalized petechiae and non‐productive cough showing bilateral ground glass consolidation. There was serological confirmation of dengue fever.
Figure 5
Figure 5
CXR of a 27‐year‐old man, a frequent hill walker in Hong Kong, who developed a right groin painless ulcer (eschar), fever, headache, myalgia and multi‐organ failure showing bilateral lower lobe ground glass consolidation. The presence of specific IgG against scrub typhus was detected by ELISA.
Figure 6
Figure 6
A high‐resolution CT thoracic scan of a 22‐year‐old man who underwent drowning in a heavily contaminated river who developed high fever, liver failure, anuria and haemoptysis, and a fourfold rise in anti‐leptospiral and IgG on ELISA showing bilateral ground glass consolidation.
Figure 7
Figure 7
CXR (posterior‐anterior and lateral views) of a 42‐year‐old Chinese man, a frequent consumer of raw fresh water crabs, who developed daily haemoptysis, chronic cough, low‐grade fever, showing right middle lobe consolidation. BAL fluid from the affected lung segment showed the presence of brown oval eggs and serology showed the presence of specific anti‐IgG against Paragonimiasis westermani.

References

    1. Yang T, Fisher KJ, Li F, Danaher BG. Attitudes to smoking cessation and triggers to relapse among Chinese male smokers. BMC Public Health 2006; 6: 65.
    1. Zaidi AK, Awasthi S, DeSilva HJ. Burden of infectious diseases in South Asia. BMJ 2004; 328: 811–15.
    1. Unicef Child Mortality Statistics. [Accessed 17 February 2004.] Available from URL:
    1. Black RE, Morris SS, Bryce J. Where and why are 10 million children dying every year? Lancet 2003; 361: 2226–34.
    1. Census and Statistics Department, Department of Health . Hong Kong Hospital Authority Statistical Report 2005/06. [Accessed 16 July 2008.]
    1. Fine MJ, Smith MA, Carson CA, Mutha SS, Sankey SS et al Prognosis and outcomes of patients with community‐acquired pneumonia. A meta‐analysis. JAMA 1996; 275: 134–41.
    1. Marston BJ, Plouffe JF, File TM Jr, Hackman BA, Salstrom SJ et al Incidence of community‐acquired pneumonia requiring hospitalization. Results of a population‐based active surveillance Study in Ohio. The Community‐Based Pneumonia Incidence Study Group. Arch. Intern. Med. 1997; 157: 1709–18.
    1. Song JH, Oh WS, Kang CI, Chung DR, Peck KR et al Epidemiology and clinical outcomes of community‐acquired pneumonia in adult patients in Asian countries: a prospective study by the Asian network for surveillance of resistant pathogens. Int. J. Antimicrob. Agents 2008; 31: 107–14.
    1. Matsushima T, Miyashita N, File TM Jr. Etiology and management of community‐acquired pneumonia in Asia. Curr. Opin. Infect. Dis. 2002; 15: 157–62.
    1. Ishida T, Miyashita N, Nakahama C. Clinical differentiation of atypical pneumonia using Japanese guidelines. Respirology 2007; 12: 104–10.
    1. Liam CK, Lim KH, Wong CM. Community‐acquired pneumonia in patients requiring hospitalization. Respirology 2001; 6: 259–64.
    1. Hui KP, Chin NK, Chow K. Prospective study of the aetiology of adult community acquired bacterial pneumonia needing hospitalisation in Singapore. Singapore Med. J. 1993; 34: 329–34.
    1. Chan CH, Cohen M, Pang J. A prospective study of community‐acquired pneumonia in Hong Kong. Chest 1992; 101: 442–46.
    1. Boonsawat W, Boonma P, Tangdajahiran T, Paupermpoonsiri S, Wongpratoom W et al Community‐acquired pneumonia in adults at Srinagarind Hospital. J. Med. Assoc. Thai. 1990; 73: 345–52.
    1. Dey AB, Chaudhry R, Kumar P, Nisar N, Nagarkar KM. Mycoplasma pneumoniae and community‐acquired pneumonia. Natl. Med. J. India. 2000; 13: 66–70.
    1. Asghar R, Banajeh S, Egas J, Hibberd P, Iqbal I et al Chloramphenicol versus ampicillin plus gentamicin for community acquired very severe pneumonia among children aged 2–59 months in low resource settings: multicentre randomised controlled trial (SPEAR study). BMJ 2008; 336: 80–4.
    1. Charles PG, Whitby M, Fuller AJ, Stirling R, Wright AA et al The etiology of community‐acquired pneumonia in Australia: why penicillin plus doxycycline or a macrolide is the most appropriate therapy. Clin. Infect. Dis. 2008; 46: 1513–21.
    1. Yin CC, Huah LW, Lin JT, Goh A, Ling H et al Lower respiratory tract infection in hospitalized children. Respirology 2003; 8: 83–9.
    1. World Health Organization . Global Tuberculosis Control. WHO Report 2001. WHO, Geneva, Switzerland, WHO/CDS/TB/2001.287.
    1. Wood R, Maartens G, Lombard CJ. Risk factors for developing tuberculosis in HIV‐1 infected adults from communities with a low or very high incidence of tuberculosis. J. Acquir. Immune. Defic. Syndr. 2000; 23: 75–80.
    1. Connolly C, Reid A, Davies G, Sturm W, McAdam KP et al Relapse and mortality among HIV infected and uninfected patients with tuberculosis successfully treated with twice weekly directly observed therapy in rural South Africa. AIDS 1999; 13: 1543–7.
    1. Hong Kong Chest Service, Tuberculosis Research Center, Madras, British Medical Research Council . A double‐blind placebo‐controlled clinical trial of three antituberculosis chemoprophylaxis regimens in patients with silicosis in Hong Kong. Am. Rev. Respir. Dis. 1992; 145: 36–41.
    1. Bentwich Z, Kalinkovich A, Weisman Z, Borkow G, Beyers N et al Can eradication of worms change the face of AIDS and tuberculosis? Immunol. Today 1999; 20: 485–7.
    1. Starke JR. Tuberculosis in children In: Reichman LB, Hershfield ES. (eds) Tuberculosis: A Comprehensive International Approach. Marcel Dekker Inc, New York, 1993; 329–67.
    1. Lucas SB, De Cock KM, Hounnou A, Peacock C, Diomande M et al Contribution of tuberculosis to slim disease in Africa. BMJ 1994; 308: 1531–3.
    1. Hargreaves NJ, Kadzakumanja O, Phiri S, Nyangulu DS, Salaniponi FM et al What causes smear‐negative pulmonary tuberculosis in Malawi, an area of high HIV seroprevalence? Int. J. Tuberc. Lung Dis. 2001; 5: 113–22.
    1. De Cock KM, Chaisson RE. Will DOTS do it? A reappraisal of tuberculosis control in countries with high rates of HIV infection. Int. J. Tuberc. Lung Dis. 1999; 3: 457–65.
    1. Colebunders R, Bastian I. A review of the diagnosis and treatment of smear‐negative pulmonary tuberculosis. Int. J. Tuberc. Lung Dis. 2000; 4: 97–107.
    1. Colditz GA, Brewer TF, Berkey CS, Wilson ME, Burdick E et al Efficacy of BCG vaccine in the prevention of tuberculosis. Meta‐analysis of the published literature. JAMA 1994; 271: 698–702.
    1. Liu YN, Chen MJ, Zhao TM, Wang H, Wang R et al A multicentre study on the pathogenic agents in 665 adult patients with community‐acquired pneumonia in cities of China. Zhonghua Jie He He Hu Xi Za Zhi 2006; 29: 3–8.
    1. Ho PL, Que TL, Chiu SS, Yung RW, Ng TK et al Fluoroquinolone and other antimicrobial resistance in invasive pneumococci, Hong Kong, 1995–2001. Emerg. Infect. Dis. 2004; 10: 1250–7.
    1. BTS Pneumonia Guidelines Committee . BTS Guidelines for the Management of Community Acquired Pneumonia in Adults—2004 updated. Published on BTS website on 30.04.04. [Accessed 18 June 2005.] Available from URL:
    1. Woodhead M, Blasi F, Ewig S, Huchon G, Ieven M et al Guidelines for the management of adult lower respiratory tract infections. Eur. Respir. J. 2005; 26: 1138–80.
    1. Miyashita N, Matsushima T, Oka M, Japanese Respiratory Society . The JRS guidelines for the management of community‐acquired pneumonia in adults: an update and new recommendations. Intern. Med. 2006; 45: 419–28.
    1. Heffelfinger JD, Dowell SF, Jorgensen JH, Klugman KP, Mabry LR et al Management of community‐acquired pneumonia in the era of pneumococcal resistance: a report from the Drug‐Resistant Streptococcus pneumoniae Therapeutic Working Group. Arch. Intern. Med. 2000; 160: 1399–408.
    1. Mandell LA, Marrie TJ, Grossman RF, Chow AW, Hyland RH. Canadian guidelines for the initial management of community‐acquired pneumonia: an evidence‐based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society. The Canadian Community‐Acquired Pneumonia Working Group. Clin. Infect. Dis. 2000; 31: 383–421.
    1. Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD et al Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community‐acquired pneumonia in adults. Clin. Infect. Dis. 2007; 44 (Suppl. 2): S27–72.
    1. Van Bambeke F, Reinert RR, Appelbaum PC, Tulkens PM, Peetermans WE. Multidrug‐resistant Streptococcus pneumoniae infections: current and future therapeutic options. Drugs 2007; 67: 2355–82.
    1. CLSI . MIC interpretive standards for Streptococcus pneumoniae. Table 2G In: Performance Standards for Antimicrobial Susceptibility Testing; Eighteenth Informational Supplement. CLSI document M100‐S18. Clinical and Laboratory Standards Institute, Wayne, PA, 2008.
    1. World Health Organization . Summary Probable SARS Cases with Onset of Illness from November 1 2002 to July 31 2003. [Accessed 26 September 2003.] Available from URL:
    1. Nicholls JM, Poon LL, Lee KC, Ng WF, Lai ST et al Lung pathology of fatal severe acute respiratory syndrome. Lancet 2003; 361: 1773–8.
    1. Tse GM, To KF, Chan PK, Lo AW, Ng KC et al Pulmonary pathological features in coronavirus associated severe acute respiratory syndrome (SARS). J. Clin. Pathol. 2004; 57: 260–5.
    1. World Health Organization . Case Definitions for Surveillance of Severe Acute Respiratory Syndrome (SARS). [Accessed 1 May 2003.] Available from URL:
    1. Center for Disease Prevention and Control . Severe Acute Respiratory Syndrome (SARS). Diagnosis/Evaluation. [Accessed 6 February 2004.] Available from URL:
    1. Tsang KW, Mok TY, Wong PC, Ooi GC. Severe acute respiratory syndrome (SARS) in Hong Kong. Respirology 2003; 8: 259–65.
    1. Ooi CG, Khong PL, Lam B, Ho JC, Yiu WC et al Severe acute respiratory syndrome: relationship between radiologic and clinical parameters. Radiology 2003; 229: 492–9.
    1. Wong WM, Ho JC, Ooi GC, Mok T, Chan J et al Temporal patterns of hepatic dysfunction and disease severity in patients with SARS. JAMA 2003; 290: 2663–5.
    1. Poon LL, Wong BW, Chan KH, Leung CS, Yuen KY et al A one step quantitative RT‐PCR for detection of SARS coronavirus with an internal control for PCR inhibitors. J. Clin. Virol. 2004; 30: 214–17.
    1. Tsang KW, Ho PL, Ooi GC, Yee WK, Wang T et al A cluster of cases of severe acute respiratory syndrome in Hong Kong. N. Engl. J. Med. 2003; 348: 1977–85.
    1. Poutanen SM, Low DE, Henry B, Finkelstein S, Rose D et al Identification of severe acute respiratory syndrome in Canada. N. Engl. J. Med. 2003; 348: 1995–2005.
    1. Chu CM, Leung YY, Hui JY, Hung IF, Chan VL et al Spontaneous pneumomediastinum in patients with severe acute respiratory syndrome. Eur. Respir. J. 2004; 23: 802–4.
    1. Loutfy MR, Blatt LM, Siminovitch KA, Ward S, Wolff B et al Interferon alfacon‐1 plus corticosteroids in severe acute respiratory syndrome: a preliminary study. JAMA 2003; 290: 3222–8.
    1. Tsang K, Zhong NS. SARS: pharmacotherapy. Respirology 2003; 8 (Suppl.): S25–30.
    1. Griffith JF, Antonio GE, Kumta SM, Hui DS, Wong JK et al Osteonecrosis of hip and knee in patients with severe acute respiratory syndrome treated with steroids. Radiology 2005; 235: 168–75
    1. Ho JC, Wu AY, Lam B, Ooi GC, Khong PL et al Pentaglobin in steroid‐resistant severe acute respiratory syndrome. Int. J. Tuberc. Lung Dis. 2004; 8: 1173–9.
    1. Apisarnthanarak A, Kitphati R, Thongphubeth K, Patoomanunt P, Anthanont P et al Atypical avian influenza (H5N1). Emerg. Infect. Dis. 2004; 10: 1321–4.
    1. WHO . Cumulative Number of Confirmed Human Cases of Avian Influenza A/(H5N1) Reported to WHO. [Accessed 19 June 2008.] Available from URL:
    1. Sandrock C, Kelly T. Clinical review: updated of avian influenza A infections in humans. Crit. Care 2007; 11: 209.
    1. Leneva IA, Goloubeva O, Fenton RJ, Tisdale M, Webster RG. Efficacy of zanamivir against avian influenza A viruses that possess genes encoding H5N1 internal proteins and are pathogenic in mammals. Antimicrob. Agents Chemother. 2001; 45: 1216–24.
    1. De Jong MD, Tran TT, Truong HK, Vo MH, Smith GJ et al Oseltamivir resistance during treatment of influenza A (H5N1) infection. N. Engl. J. Med. 2005; 353: 2667–72.
    1. Treanor JJ, Hayden FG, Vrooman PS, Barbarash R, Bettis R et al Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group. JAMA 2000; 283: 1016–24.
    1. Tran TH, Nguyen TL, Nguyen TD, Luong TS, Pham PM et al Avian influenza A (H5N1) in 10 patients in Vietnam. N. Engl. J. Med. 2004; 350: 1179–88.
    1. Tsang KW, Eng P, Liam CK, Shim YS, Lam WK. H5N1 influenza pandemic: contingency plans. Lancet 2005; 366: 533–4.
    1. Annane D, Bellissant E, Bollaert PE, Briegel J, Keh D et al Corticosteroids for severe sepsis and septic shock: a systematic review and meta‐analysis. BMJ 2004; 329: 480.
    1. Confalonieri M, Urbino R, Potena A, Piattella M, Parigi P et al Hydrocortisone infusion for severe community‐acquired pneumonia: a preliminary randomized study. Am. J. Respir. Crit. Care Med. 2005; 171: 242–8.
    1. Tsang KW, Shim YS, Wong TK, Liam CK, Eng P et al Possible case scenarios and logistic issues in H5N1 pandemic. Respirology 2006; 11: 520–2.
    1. Maneechotesuwan K. An exotic pulmonary infection in Thailand: melioidosis. Respirology 1999; 4: 419–22.
    1. Rigau‐Pérez JG, Clark GG, Gubler DJ, Reiter P, Sanders EJ et al Dengue and dengue haemorrhagic fever. Lancet 1998; 352: 971–7.
    1. Berman SJ, Kundin WD. Scrub typhus in South Vietnam. Ann. Intern. Med. 1973; 79: 26–30.
    1. Watt G, Parola P. Scrub typhus and tropical rickettsioses. Curr. Opin. Infect. Dis. 2003; 16: 429–36.
    1. McBride AJ, Athanazio DA, Reis MG, Ko AI. Leptospirosis. Curr. Opin. Infect. Dis. 2005; 18: 376–86.
    1. Saphra I, Winter JW. Clinical manifestations of salmonellosis in man. An evaluation of 7779 human infections identified at the New York Salmonella Center. N. Engl. J. Med. 1957; 256: 22–34.
    1. Hoag JB, Sessler CN. A comprehensive review of disseminated Salmonella arizona infection with an illustrative case presentation. South Med. J. 2005; 98: 1123–9.
    1. Duong TA. Infection due to Penicillium marneffei, an emerging pathogen: review of 155 reported cases. Clin. Infect. Dis. 1996; 23: 125–30.
    1. Gachot B, Wolff M, Nissack G, Veber B, Vachon F. Acute lung injury complicating imported Plasmodium falciparum malaria. Chest 1995; 108: 746–9.
    1. Vijayan VK. How to diagnose and manage common parasitic pneumonias. Curr. Opin. Pulm. Med. 2007; 13: 218–24.
    1. Shamsuzzaman SM, Hashiguchi Y. Thoracic amebiasis. Clin. Chest Med. 2002; 23: 479–92.
    1. Im JG, Chang KH, Reeder MM. Current diagnostic imaging of pulmonary and cerebral paragonimiasis, with pathological correlation. Semin. Roentgenol. 1997; 32: 301–24.
    1. Maleewong W. Recent advances in diagnosis of paragonimiasis. Southeast Asian J. Trop. Med. Public Health 1997; 28 (Suppl. 1): 134–8.
    1. Chu E, Whitlock WL, Dietrich RA. Pulmonary hyperinfection syndrome with Strongyloides stercoralis. Chest 1990; 97: 1475–7.
    1. Sun T. Gnathostomiasis In: Sun T. (ed.) Parasitic Disorders: Pathology, Diagnosis, and Management, 2nd edn. Williams & Wilkins, Baltimore, MD, 1999; 225–31.
    1. Winter MD, Ball ML, Altringham JD, Lee DL. The effect of Trichinella spiralis and Trichinella pseudospiralis on the mechanical properties of mammalian diaphragm muscle. Parasitology 1994; 109: 129–34.
    1. Barret‐Connor E. Parasitic pulmonary disease. Am. Rev. Respir. Dis. 1982; 126: 558–63.
    1. Safioleas M, Misiakos EP, Dosios T, Manti C, Lambrou P et al Surgical treatment for lung hydatid disease. World J. Surg. 1999; 23: 1181–5.
    1. Butterworth AE, David JR. Eosinophil function. N. Engl. J. Med. 1981; 304: 154–6.
    1. Muller GL. Clinical significance of the blood in tuberculosis. Commonwealth Fund, New York, 1943; 95–121.
    1. Neva FA, Ottesen EA. Tropical (filarial) eosinophilia. N. Engl. J. Med. 1978; 298: 1129–31.
    1. Jain VK, Beniwal OP. Unusual presentation of tropicalpulmonary eosinophilia. Thorax 1984; 39: 634–5.
    1. Joshi VV, Udwadia FE, Gadgil RK. Etiology of tropical eosinophilia: a study of lung biopsies and review of published reports. Am. J. Trop. Med. Hyg. 1969; 18: 231–40.

Source: PubMed

3
Abonneren